2017年8月31日，EndPoints发布了《The top 10 biopharma CROs in the world—mid-2017 edition》。
1
QuintilesIMS
Durham, NC
Market cap: $20.7B
2016 Revenue: $5.4B
Employees: 50,000
CEO: Ari Bousbib
2
LabCorp/Covance
Burlington, NC / Priceton, NJ
Market Cap: $15.66B
2016 Diagnostics Revenue: $6.6B
2016 Covance Revenue: $2.8B
LabCorp Employees: 36,000
Covance Employees: 16,000
LabCorp CEO: David King
Covance CEO: John Ratliff
3
PPD Private
Wilmington, NC
Private valuation: $9.05B
Employees: 19,000
CEO: David Simmons
4
Icon
Dublin, Ireland
Market Cap: $6.08B
2016 Revenue: $1.7B
Employees: 12,500
CEO: Steve Cutler
5
INC Research/inVentiv Health
Morrisville, NC (future)
Market Cap: $6.04B
2016 Revenue: $2.1B
Employees: 22,000
CEO: Alistair Macdonald
6
PRA Health Sciences
Raleigh, NC
Market Cap: $4.8B
2016 Revenue: $1.8B
Employees: 13,000
CEO: Colin Shannon
7
Parexel
Waltham, MA
Market Cap: $4.5B
2016 Revenue: $2.1B
Employees: 18,900
CEO: Josef von Rickenbach
8
BioClinica Private
Doylestown, PA
Private valuation: $1.4B
CEO: John Hubbard
9
Medpace
Cincinnati, OH
Market Cap: $1.2B
2016 Revenue: $371M
Employees: 2,500
CEO: August Troendle
10+
Premier Research Private
Durham, NC
CEO: Ludo Reynders
Worldwide Clinical Trials Private
Morrisville, NC
CEO: Neal Cutler
PSI Private
Zug, Switzerland
CEO: Nick Sinackevich
参考资料及重要声明：
The top 10 biopharma CROs in the world—mid-2017 edition（作者：arsalan arif，发表时间：2017年8月31日）
图片来源：原文、公司官网、Google，等。
所有版权归拥有者！
药时代编译，旨在分享有价值的信息，仅供个人学习参考。欢迎阅读原文，对译文批评指正！衷心感谢！
—— 欢迎阅读近3个月内10,000+文章！——
欢迎联系我们！[email protected]
